Bronson Crouch
Directeur Général chez INSTIL BIO, INC.
Fortune : 22 M $ au 30/04/2024
Profil
Bronson Crouch is currently the Chairman & Chief Executive Officer at Instil Bio, Inc. He is also a Managing Partner at Peloton Therapeutics, Inc., TCR2 Therapeutics, Inc., and iTeos Therapeutics, Inc. Additionally, he is a Founding Partner at Curative Ventures Management LLC.
Previously, he was a Managing Partner at CoStim Pharmaceuticals, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INSTIL BIO, INC.
32,99% | 16/04/2024 | 2 145 895 ( 32,99% ) | 22 M $ | 30/04/2024 |
Postes actifs de Bronson Crouch
| Sociétés | Poste | Début |
|---|---|---|
| INSTIL BIO, INC. | Directeur Général | 01/11/2018 |
| TCR2 THERAPEUTICS INC. | Corporate Officer/Principal | - |
| PELOTON THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| ITEOS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Curative Ventures Management LLC
 Curative Ventures Management LLC Investment ManagersFinance Curative Ventures Management LLC (Curative Ventures) is a venture capital firm founded in 2010. The firm is headquartered in Dallas, Texas. | Private Equity Investor | 01/01/2014 |
Anciens postes connus de Bronson Crouch
| Sociétés | Poste | Fin |
|---|---|---|
CoStim Pharmaceuticals, Inc.
 CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INSTIL BIO, INC. | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Curative Ventures Management LLC
Curative Ventures Management LLC Investment ManagersFinance Curative Ventures Management LLC (Curative Ventures) is a venture capital firm founded in 2010. The firm is headquartered in Dallas, Texas. | Finance |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Peloton Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. Its lead drug candidate is a small molecule which targets HIF-2a, a transcription factor implicated in the development and progression of renal and other cancers. The company was founded by Steven L. McKnight in August 2010 and is headquartered in Dallas, TX. | Health Technology |